Volume 24, Number 1—January 2018
Research
Characterization of a Feline Influenza A(H7N2) Virus
Table 4
Virus |
Transmission mode |
Pair |
Action |
Virus titers in nasal swab samples by days postinfection, exposure, or contact, log10(PFU/mL) | Sero-conversion (HI titer)† | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
1 |
3 |
5 |
7 |
9 |
11 |
13 |
|||||
A/feline/NY/16 | Respiratory droplets | Pair 1 | Infection | 5.6 | 4.7 | 4.3 | 3.0 | – | – | – | 320 |
Exposure |
– |
– |
– |
– |
5.2 |
– |
– |
160 |
|||
Pair 2 | Infection | 4.5 | 2.7 | 5.0 | 4.6 | – | – | – | 320 | ||
Exposure |
– |
– |
– |
– |
– |
5.4 |
– |
80 |
|||
Pair 3 | Infection | 4.8 | 3.2 | 5.3 | 3.6 | – | – | – | 320 | ||
Exposure |
– |
– |
– |
– |
– |
– |
– |
<10 |
|||
Direct contact | Pair 1 | Infection | 5.9 | 4.6 | 3.4 | – | – | – | – | 320 | |
Contact |
– |
– |
2.0 |
5.4 |
– |
– |
– |
320 |
|||
Pair 2 | Infection | 6.0 | 5.0 | 4.6 | – | – | – | – | 640 | ||
Contact |
– |
– |
– |
– |
– |
– |
– |
80 |
|||
Pair 3 | Infection | 4.9 | 4.9 | 4.4 | 4.2 | – | – | – | 640 | ||
Contact |
– |
5.2 |
5.4 |
5.2 |
– |
– |
– |
160 |
|||
A/chicken/NY/99 | Respiratory droplets | Pair 1 | Infection | 4.0 | 3.7 | 4.7 | – | – | – | – | 320 |
Exposure |
– |
– |
– |
– |
– |
– |
– |
20 |
|||
Pair 2 | Infection | – | – | – | – | – | – | – | 320 | ||
Exposure |
– |
– |
– |
– |
– |
– |
– |
20 |
|||
Pair 3 | Infection | 2.6 | 1.6 | 2.3 | – | – | – | – | 80 | ||
Exposure |
– |
– |
– |
– |
– |
– |
– |
160 |
|||
Direct contact | Pair 1 | Infection | 4.5 | 2.4 | 4.5 | – | – | – | – | 80 | |
Contact |
– |
– |
– |
– |
– |
– |
– |
160 |
|||
Pair 2 | Infection | 3.4 | 4.8 | 4.1 | 3.6 | – | – | – | 160 | ||
Contact |
– |
– |
– |
– |
– |
– |
– |
40 |
|||
Pair 3 | Infection | 3.4 | 3.5 | 3.2 | 3.3 | – | – | – | 160 | ||
Contact | – | – | – | – | – | – | – | 20 |
*–, no virus detected.
†Serum samples were collected on day 18 after infection, exposure, or contact, and examined by use of an HI assay. The HI titer is the inverse of the highest dilution of serum that completely inhibited hemagglutination.
1These authors contributed equally to this article.
Page created: December 19, 2017
Page updated: December 19, 2017
Page reviewed: December 19, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.